These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1149 related articles for article (PubMed ID: 6467174)
1. The action of two Vinca alkaloids on B16 melanoma in vitro. Donoso JA; Himes RH Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Jordan MA; Himes RH; Wilson L Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells. Howard SM; Theologides A; Sheppard JR Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211 [TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells. Van Belle SJ; De Smet MC; De Mey JE; Storme GA Anticancer Res; 1991; 11(1):465-71. PubMed ID: 2018383 [TBL] [Abstract][Full Text] [Related]
5. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids]. Kubota R; Kubota K; Yamada S Gan To Kagaku Ryoho; 1992 Nov; 19(13):2163-7. PubMed ID: 1444481 [TBL] [Abstract][Full Text] [Related]
6. Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells: the basis of differential toxicity. Ferguson PJ; Cass CE Cancer Res; 1985 Nov; 45(11 Pt 1):5480-8. PubMed ID: 3863705 [TBL] [Abstract][Full Text] [Related]
7. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment. Al-Ahmad A; Kümmerer K Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417 [TBL] [Abstract][Full Text] [Related]
8. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266 [TBL] [Abstract][Full Text] [Related]
9. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay. Owellen RJ; Blair M; Van Tosh A; Hains FC Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468 [TBL] [Abstract][Full Text] [Related]
10. Differential activity of vincristine and vinblastine against cultured cells. Ferguson PJ; Phillips JR; Selner M; Cass CE Cancer Res; 1984 Aug; 44(8):3307-12. PubMed ID: 6744266 [TBL] [Abstract][Full Text] [Related]
11. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia. Chello PL; Sirotnak FM Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551 [TBL] [Abstract][Full Text] [Related]
12. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Himes RH; Kersey RN; Heller-Bettinger I; Samson FE Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003 [TBL] [Abstract][Full Text] [Related]
13. Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells. King KL; Boder GB Cancer Chemother Pharmacol; 1979; 2(4):239-42. PubMed ID: 455582 [TBL] [Abstract][Full Text] [Related]
14. Block of axoplasmic transport in vitro by vinca alkaloids. Chan SY; Worth R; Ochs S J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229 [TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids. Pereira E; Tarasiuk J; Garnier-Suillerot A Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556 [TBL] [Abstract][Full Text] [Related]
16. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids. Poppitt DG; McGown AT; Fox BW Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of murine CFU-C by vindesine: restoration of colony growth by colony stimulating factor. Pigoli G; Mangoni L; Caramatti C; Degliantoni G; Rizzoli V Int J Cell Cloning; 1983 Jul; 1(3):142-50. PubMed ID: 6609213 [TBL] [Abstract][Full Text] [Related]
18. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity. Lobert S; Frankfurter A; Correia JJ Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953 [TBL] [Abstract][Full Text] [Related]
19. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine. Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658 [TBL] [Abstract][Full Text] [Related]
20. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents. Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]